Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05924295Recruiting
Open-label, single-arm trial, sponsored by The Ohio State University. Primary endpoint: Capillary d-beta-hydroxybutyrate at 4 hours. Started Jun 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05924295.